With rising demand and an ageing population, European healthcare systems are under strain. In the second article in our ...

When it comes to neurodegenerative conditions such as Alzheimer’s, Parkinson’s and Huntington’s Disease, not to mention motor ...

When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...

Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.

With their help, we were able to identify a specific TMEM16F mutation which is common in Ashkenazi Jews in general ... new target for the development of effective treatments for Parkinson’s disease.

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

Nearly one million people in the U.S. are living with Parkinson's Disease. Playhouse Square is rolling out a new program to ...

According to the researchers, this mutation increases TMEM16F activity, which impacts how cells release substances from their membranes. The faulty alpha-synuclein is then picked up by nearby healthy ...

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

With their help, we were able to identify a specific TMEM16F mutation which is common in Ashkenazi Jews in general ... new ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...